Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
Net Protections ¥67.7 billion IPO
The shares are listed on the Tokyo Stock Exchange
Target Global Acquisition I $200 million IPO
We advised Target Global Acquisition I, a SPAC, on its IPO and Nasdaq listing
CANbridge Pharmaceuticals HK$685 million IPO
We advised CANbridge Pharmaceuticals on its IPO and HKEX listing
SS&C Technologies acquisition of Hubwise
We are advising SS&C Technologies on the transaction
Olympus $500 million senior notes offering
The debut offering consisted of 2.143% senior notes due 2026
Alm. Brand DKK 10.47 billion rights offering
The offering included 1,387,026,000 shares
SS&C Technologies £1.24 billion offer for Blue Prism
We are advising SS&C Technologies on the recommended cash offer
NXP $2 billion senior notes offering
The investment-grade notes are due 2032, 2042 and 2051
Banco Santander renovation of $25 billion U.S. commercial paper program
We advised Banco Santander on its program renovation
Banco Santander $1 billion Tier 2 notes offering
We advised Banco Santander on its offering of 3.225% Tier 2 subordinated callable fixed-to-fixed-rate notes due 2032